Cosmetic GMP under MoCRA (21 CFR 711) and batch records

MoCRA did more than require US cosmetic brands to register and list their products. It also set the stage for mandatory good manufacturing practice — formal rules for how cosmetics must be made. As the FDA develops cosmetic GMP, manufacturers face a shift from make it well as good practice to make it to a standard, and prove it as law. Here is what is coming and what it means.

From voluntary quality to mandatory GMP

Historically, good manufacturing practice for cosmetics in the US was a matter of guidance and good sense rather than binding regulation. MoCRA changed the trajectory by directing the FDA to establish cosmetic GMP requirements — expected to live in a dedicated part of the regulations, often referenced as 21 CFR part 711 — that will carry the force of law.

The direction is clear even as the detail is finalised: cosmetic manufacturing is moving toward enforceable, documented standards.

What cosmetic GMP covers

GMP frameworks across regulated products share a common shape, and cosmetic GMP is expected to follow it: requirements covering personnel, facilities and equipment, raw materials and components, production and process controls, laboratory or testing controls, recordkeeping, and handling of complaints and deviations.

The throughline is consistency and traceability — making the product the same way every time, and being able to show that you did.

The records at the heart of it

As with supplement cGMP, the documentation is central. A GMP regime expects records that define how a product is made and evidence that each batch was made that way — the master formula and method, and the batch records that prove conformance. Deviations and complaints have to be logged and handled. When an inspector or an auditor asks, the records are the answer.

Cosmetic brands that have treated documentation casually will find this the biggest adjustment.

Why this connects to the rest of MoCRA

Cosmetic GMP does not stand alone. It connects to product listing (which describes the product), to safety substantiation (which rests on the composition), and to the records the Responsible Person must keep. A brand that has its composition, specifications, and records in order for GMP is also better placed for the listing and safety obligations — they draw on the same underlying data.

Because cosmetic GMP rules are still being finalised, confirm the current and forthcoming requirements for your operation rather than relying on a general summary.

The version-control foundation

Underlying GMP is the same discipline that underlies supplement cGMP: version control. A cosmetic formula evolves, and its master record must evolve with it, with a clear current version and a history of what changed. Without that, you cannot reliably reproduce a batch or demonstrate conformance — the two things GMP exists to ensure.

Building toward GMP readiness

The reliable approach is to hold each cosmetic formula under version control, with its specifications and records derived from the structured composition, so the master record reflects the current product and a full history is preserved. As cosmetic GMP becomes enforceable, brands built this way are ready by construction rather than scrambling to retrofit documentation onto a loose process.

The takeaway

MoCRA is bringing mandatory good manufacturing practice to US cosmetics, expected under a dedicated regulation, built on consistency, traceability, and records — the master formula, the batch records, the deviation and complaint logs. It rests on the same version-controlled, structured data as the rest of MoCRA's obligations. Brands that put that foundation in place now are preparing for GMP rather than reacting to it.

Lemoniq holds every cosmetic formula under version control with specifications and a full audit trail, so the records cosmetic GMP will demand stay consistent with the current product and reproducible batch to batch. We solve this exact problem. See how it works